The Molecular Biology and Pathophysiology of Vascular Calcification

References

• . Thompson GR, Partridge J. Coronary calcification score: the coronaryrisk impact factor. Lancet. 2004;363(9408):557–559
   PubMed Web of Science ®Google Scholar
• . Detrano R, Guerci AD, Carr JJ, . Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336–1345
   PubMed Web of Science ®Google Scholar
• . Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag. 2009;5(1):185–197
   PubMedGoogle Scholar
• . Ferro CJ, Chue CD, Steeds RP, Townend JN. Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart. 2009;95(21):1770–1772
   PubMed Web of Science ®Google Scholar
• . Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21(5):1220–1225
   PubMed Web of Science ®Google Scholar
• . Fox CS, Vasan RS, Parise H, . Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation. 2003;107(11):1492–1496
   PubMed Web of Science ®Google Scholar
• . Fox CS, Parise H, Vasan RS, . Mitral annular calcification is a predictor for incident atrial fibrillation. Atherosclerosis. 2004;173(2):291–294
   PubMed Web of Science ®Google Scholar
• . Potpara TS, Vasiljevic ZM, Vujisic-Tesic BD, . Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study. Chest. 2011;140(4):902–910
   PubMed Web of Science ®Google Scholar
• . De Marco M, Gerdts E, Casalnuovo G, . Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study. Am J Hypertens. 2013;26(4):567–573
   PubMed Web of Science ®Google Scholar
• . Ehara S, Kobayashi Y, Yoshiyama M, . Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004;110(22):3424–3429
   PubMed Web of Science ®Google Scholar
• . Ewence AE, Bootman M, Roderick HL, . Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res. 2008;103(5):e28–e34
   Web of Science ®Google Scholar
• . Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res. 1998;13(5):828–838
   PubMed Web of Science ®Google Scholar
• . Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol. 2004;15(12):2959–2964
   PubMed Web of Science ®Google Scholar
• . Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89(5):747–754
   PubMed Web of Science ®Google Scholar
• . Speer MY, Li X, Hiremath PG, Giachelli CM. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem. 2010;110(4):935–947
   PubMed Web of Science ®Google Scholar
• . Chen NX, Duan D, O'Neill KD, . The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int. 2006;70(6):1046–1053
   PubMed Web of Science ®Google Scholar
• . Byon CH, Javed A, Dai Q, . Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283(22):15319–15327
   PubMed Web of Science ®Google Scholar
• . Xiao G, Jiang D, Ge C, . Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem. 2005;280(35):30689–30696
   PubMed Web of Science ®Google Scholar
• . Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev. 2013;19(3):254–263
   PubMed Web of Science ®Google Scholar
• . Zhao G, Xu MJ, Zhao MM, . Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int. 2012;82(1):34–44
   PubMed Web of Science ®Google Scholar
• . Jono S, McKee MD, Murry CE, . Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10–E17
   PubMed Web of Science ®Google Scholar
• . Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int. 2009;75(9):890–897
   PubMed Web of Science ®Google Scholar
• . Linefsky JP, O'Brien KD, Katz R, . Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study. J Am Coll Cardiol. 2011;58(3):291–297
   PubMed Web of Science ®Google Scholar
• . Adeney KL, Siscovick DS, Ix JH, . Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20(2):381–387
   PubMed Web of Science ®Google Scholar
• . Gutierrez OM. Increased serum phosphate and adverse clinical outcomes: unraveling mechanisms of disease. Curr Opin Nephrol Hypertens. 2011;20(3):224–228
   PubMed Web of Science ®Google Scholar
• . Cancela AL, Santos RD, Titan SM, . Phosphorus is associated with coronary artery disease in patients with preserved renal function. PLoS ONE. 2012;7(5):e36883
   Web of Science ®Google Scholar
• . Figueiredo CP, Rajamannan NM, Lopes JB, . Serum phosphate and hip bone mineral density as additional factors for high vascular calcification scores in a community-dwelling: the Sao Paulo Ageing and Health Study (SPAH). Bone. 2013;52(1):354–359
   PubMed Web of Science ®Google Scholar
• . Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res. 2005;97(2):105–114
   PubMed Web of Science ®Google Scholar
• . Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA. Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun. 2011;413(3):436–441
   PubMed Web of Science ®Google Scholar
• . Ren X, Shao H, Wei Q, Sun Z, Liu N. Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res. 2009;37(3):847–854
   PubMed Web of Science ®Google Scholar
• . Suga T, Iso T, Shimizu T, . Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb. 2011;18(8):670–683
   PubMed Web of Science ®Google Scholar
• . Wang Z, Jiang Y, Liu N, . Advanced glycation end-product Nepsiloncarboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Atherosclerosis. 2012;221(2):387–396
   PubMed Web of Science ®Google Scholar
• . Wei Q, Ren X, Jiang Y, Jin H, Liu N, Li J. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. BMC Cardiovasc Disord. 2013;13:13
   PubMed Web of Science ®Google Scholar
• . Hofmann Bowman MA, Gawdzik J, Bukhari U, . S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program. Arterioscler Thromb Vasc Biol. 2011;31(2):337–344
   PubMed Web of Science ®Google Scholar
• . Gawdzik J, Mathew L, Kim G, Puri TS, Hofmann Bowman MA. Vascular remodeling and arterial calcification are directly mediated by S100A12 (EN-RAGE) in chronic kidney disease. Am J Nephrol. 2011;33(3):250–259
   PubMed Web of Science ®Google Scholar
• . Towler DA. Vascular calcification: it's all the RAGE! Arterioscler Thromb Vasc Biol. 2011;31(2):237–239
   PubMed Web of Science ®Google Scholar
• . Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant. 2008;23(6):1892–1901
   PubMed Web of Science ®Google Scholar
• . Muteliefu G, Enomoto A, Jiang P, Takahashi M, Niwa T. Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells. Nephrol Dial Transplant. 2009;24(7):2051–2058
   PubMed Web of Science ®Google Scholar
• . Al-Aly Z. Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl Res. 2008;151(5):233–239
   PubMed Web of Science ®Google Scholar
• . Lee HL, Woo KM, Ryoo HM, Baek JH. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun. 2010;391(1):1087–1092
   PubMed Web of Science ®Google Scholar
• . Lencel P, Delplace S, Pilet P, . Cell-specific effects of TNF-alpha and IL-1beta on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification. Lab Invest. 2011;91(10):1434–1442
   PubMed Web of Science ®Google Scholar
• . Lai CF, Shao JS, Behrmann A, Krchma K, Cheng SL, Towler DA. TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts. Endocrinology. 2012;153(8):3897–3910
   PubMed Web of Science ®Google Scholar
• . Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006;99(10):1044–1059
   PubMed Web of Science ®Google Scholar
• . Weissen-Plenz G, Nitschke Y, Rutsch F. Mechanisms of arterial calcification: spotlight on the inhibitors. Adv Clin Chem. 2008;46:263–293
   PubMed Web of Science ®Google Scholar
• . Briand M, Lemieux I, Dumesnil JG, . Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol. 2006;47(11):2229–2236
   PubMed Web of Science ®Google Scholar
• . Katz R, Budoff MJ, Takasu J, . Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes. 2009;58(4):813–819
   PubMed Web of Science ®Google Scholar
• . Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(11):5454–5461
   PubMed Web of Science ®Google Scholar
• . Ibebuogu UN, Ahmadi N, Hajsadeghi F, . Measures of coronary artery calcification and association with the metabolic syndrome and diabetes. J Cardiometab Syndr. 2009;4(1):6–11
   PubMedGoogle Scholar
• . Narla V, Santos RD, Campbell CY, . Coronary artery calcification and inflammation according to various metabolic syndrome definitions. J Cardiometab Syndr. 2009;4(1):33–39
   PubMedGoogle Scholar
• . Tison GH, Blaha MJ, Budoff MJ, . The relationship of insulin resistance and extracoronary calcification in the multi-ethnic study of atherosclerosis. Atherosclerosis. 2011;218(2):507–510
   PubMed Web of Science ®Google Scholar
• . Capoulade R, Clavel MA, Dumesnil JG, . Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol. 2012;60(3):216–223
   PubMed Web of Science ®Google Scholar
• . Blaha MJ, DeFilippis AP, Rivera JJ, . The relationship between insulin resistance and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2011;34(3):749–751
   PubMed Web of Science ®Google Scholar
• . Jensky NE, Criqui MH, Wright CM, Wassel CL, Alcaraz JE, Allison MA. The association between abdominal body composition and vascular calcification. Obesity (Silver Spring). 2011;19(12):2418–2424
   PubMed Web of Science ®Google Scholar
• . Bremer AA, Devaraj S, Jialal I. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011;96(11):E1782–E1788
   Web of Science ®Google Scholar
• . Maahs DM, Ogden LG, Kinney GL, . Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation. 2005;111(6):747–753
   PubMed Web of Science ®Google Scholar
• . Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, Liao EY. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res. 2009;24(8):1461–1468
   PubMed Web of Science ®Google Scholar
• . Son BK, Akishita M, Iijima K, . Adiponectin antagonizes stimulatory effect of tumor necrosis factor-alpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5′-monophosphate-activated protein kinase. Endocrinology. 2008;149(4):1646–1653
   PubMed Web of Science ®Google Scholar
• . Qasim A, Mehta NN, Tadesse MG, . Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol. 2008;52(3):231–236
   PubMed Web of Science ®Google Scholar
• . Reilly MP, Iqbal N, Schutta M, . Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(8):3872–3878
   PubMed Web of Science ®Google Scholar
• . Zeadin M, Butcher M, Werstuck G, Khan M, Yee CK, Shaughnessy SG. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2009;29(12):2069–2075
   PubMed Web of Science ®Google Scholar
• . Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res. 2001;88(9):954–960
   PubMed Web of Science ®Google Scholar
• . Zeadin MG, Butcher MK, Shaughnessy SG, Werstuck GH. Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3beta. Biochem Biophys Res Commun. 2012;425(4):924–930
   PubMed Web of Science ®Google Scholar
• . Fitch K, Abbara S, Lee H, . Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS. 2012;26(5):587–597
   PubMed Web of Science ®Google Scholar
• . Liu H, Lu Q, Huang K. Selenium suppressed hydrogen peroxide-induced vascular smooth muscle cells calcification through inhibiting oxidative stress and ERK activation. J Cell Biochem. 2010;111(6):1556–1564
   PubMed Web of Science ®Google Scholar
• . Guilgen G, Werneck ML, de Noronha L, . Increased calcification and protein nitration in arteries of chronic kidney disease patients. Blood Purif. 2011;32(4):296–302
   PubMed Web of Science ®Google Scholar
• . Liberman M, Bassi E, Martinatti MK, . Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28(3):463–470
   PubMed Web of Science ®Google Scholar
• . Miller JD, Chu Y, Brooks RM, Richenbacher WE, Pena-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol. 2008;52(10):843–850
   PubMed Web of Science ®Google Scholar
• . Towler DA. Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype. Arterioscler Thromb Vasc Biol. 2005;25(4):651–654
   PubMed Web of Science ®Google Scholar
• . Li L, Mamputu JC, Wiernsperger N, Renier G. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes. 2005;54(7):2227–2234
   PubMed Web of Science ®Google Scholar
• . Schroeter MR, Leifheit-Nestler M, Hubert A, . Leptin promotes neointima formation and smooth muscle cell proliferation via NADPH oxidase activation and signalling in caveolin-rich microdomains. Cardiovasc Res. 2013;99(3):555–565
   PubMed Web of Science ®Google Scholar
• . Jiang F, Lim HK, Morris MJ, . Systemic upregulation of NADPH oxidase in diet-induced obesity in rats. Redox Rep. 2011;16(6):223–229
   PubMed Web of Science ®Google Scholar
• . Lanone S, Bloc S, Foresti R, . Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J. 2005;19(13):1890–1892
   PubMedGoogle Scholar
• . Matsumoto H, Ishikawa K, Itabe H, Maruyama Y. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem. 2006;291(1–2):21–28
   PubMed Web of Science ®Google Scholar
• . Jiang F, Roberts SJ, Datla S, Dusting GJ. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension. 2006;48(5):950–957
   PubMed Web of Science ®Google Scholar
• . Datla SR, Dusting GJ, Mori TA, Taylor CJ, Croft KD, Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension. 2007;50(4):636–642
   PubMed Web of Science ®Google Scholar
• . Zhang ZY, Bian LQ, Kim SJ, Zhou CC, Choi YH. Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males. Clin Cardiol. 2012;35(5):301–306
   PubMed Web of Science ®Google Scholar
• . Lin TH, Tang CH, Hung SY, . Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. J Cell Physiol. 2010;222(3):757–768
   PubMed Web of Science ®Google Scholar
• . Zhang B, Tang C, Du J. Changes of heme oxygenase-carbon monoxide system in vascular calcification in rats. Life Sci. 2003;72(9):1027–1037
   PubMed Web of Science ®Google Scholar
• . Jiang CQ, Lao XQ, Yin P, . Smoking, smoking cessation and aortic arch calcification in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis. 2009;202(2):529–534
   PubMed Web of Science ®Google Scholar
• . Lambrechtsen J, Gerke O, Egstrup K, . The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy. J Intern Med. 2012;271(5):444–450
   PubMed Web of Science ®Google Scholar
• . Hirooka N, Kadowaki T, Sekikawa A, . Influence of cigarette smoking on coronary artery and aortic calcium among random samples from populations of middle-aged Japanese and Korean men. J Epidemiol Community Health. 2013;67(2):119–124
   PubMed Web of Science ®Google Scholar
• . Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol. 2004;24(6):1031–1036
   PubMed Web of Science ®Google Scholar
• . Orosz Z, Csiszar A, Labinskyy N, . Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol. 2007;292(1):H130–H139
   PubMed Web of Science ®Google Scholar
• . Shih RH, Cheng SE, Hsiao LD, Kou YR, Yang CM. Cigarette smoke extract upregulates heme oxygenase-1 via PKC/NADPH oxidase/ROS/PDGFR/PI3K/Akt pathway in mouse brain endothelial cells. J Neuroinflammation. 2011;8:104
   PubMed Web of Science ®Google Scholar
• . Cheng SE, Lee IT, Lin CC, Kou YR, Yang CM. Cigarette smoke particle-phase extract induces HO-1 expression in human tracheal smooth muscle cells: role of the c-Src/NADPH oxidase/MAPK/Nrf2 signaling pathway. Free Radic Biol Med. 2010;48(10):1410–1422
   PubMed Web of Science ®Google Scholar
• . Talbot S, Lin JC, Lahjouji K, . Cigarette smoke-induced kinin B1 receptor promotes NADPH oxidase activity in cultured human alveolar epithelial cells. Peptides. 2011;32(7):1447–1456
   PubMed Web of Science ®Google Scholar
• . Asano H, Horinouchi T, Mai Y, . Nicotine- and tar-free cigarette smoke induces cell damage through reactive oxygen species newly generated by PKC-dependent activation of NADPH oxidase. J Pharmacol Sci. 2012;118(2):275–287
   PubMed Web of Science ®Google Scholar
• . Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res. 2006;98(7):905–912
   PubMed Web of Science ®Google Scholar
• . Villa-Bellosta R, Bogaert YE, Levi M, Sorribas V. Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol. 2007;27(5):1030–1036
   PubMed Web of Science ®Google Scholar
• . Zhao MM, Xu MJ, Cai Y, . Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int. 2011;79(10):1071–1079
   PubMed Web of Science ®Google Scholar
• . Sutra T, Morena M, Bargnoux AS, Caporiccio B, Canaud B, Cristol JP. Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media. Free Radic Res. 2008;42(9):789–797
   PubMed Web of Science ®Google Scholar
• . Kim H, Kim HJ, Lee K, . alpha-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J Cell Mol Med. 2012;16(2):273–286
   PubMed Web of Science ®Google Scholar
• . Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87(11):1055–1062
   PubMed Web of Science ®Google Scholar
• . Kircelli F, Peter ME, Sevinc OE, . Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 2012;27(2):514–521
   PubMed Web of Science ®Google Scholar
• . Louvet L, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant. 2013;28(4):869–878
   PubMed Web of Science ®Google Scholar
• . Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int. 1987;32(3):388–394
   PubMed Web of Science ®Google Scholar
• . Wei M, Esbaei K, Bargman J, Oreopoulos DG. Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int. 2006;26(3):366–373
   PubMed Web of Science ®Google Scholar
• . Ishimura E, Okuno S, Kitatani K, . Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol. 2007;68(4):222–227
   PubMed Web of Science ®Google Scholar
• . Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol. 2008;40(4):1075–1082
   PubMed Web of Science ®Google Scholar
• . Zheng J, Inoguchi T, Sasaki S, . Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R110–R120
   PubMed Web of Science ®Google Scholar
• . McCarty MF. Clinical potential of Spirulina as a source of phycocyanobilin. J Med Food. 2007;10(4):566–570
   PubMed Web of Science ®Google Scholar
• . Romay C, Gonzalez R, Ledon N, Remirez D, Rimbau V. C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci. 2003;4(3):207–216
   PubMed Web of Science ®Google Scholar
• . Riss J, Decorde K, Sutra T, . Phycobiliprotein C-Phycocyanin from Spirulina platensis is powerfully responsible for reducing oxidative stress and NADPH oxidase expression induced by an atherogenic diet in hamsters. J Agric Food Chem. 2007;55(19):7962–7967
   PubMed Web of Science ®Google Scholar
• . Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcystein—a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355–359
   PubMed Web of Science ®Google Scholar
• . Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008;8(12):1955–1962
   PubMed Web of Science ®Google Scholar
• . Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation. 2003;107(7):992–995
   PubMed Web of Science ®Google Scholar
• . Flier J, Van Muiswinkel FL, Jongenelen CA, Drukarch B. The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. Free Radic Res. 2002;36(6):695–699
   PubMed Web of Science ®Google Scholar
• . Cao Z, Tsang M, Zhao H, Li Y. Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury. Biochem Biophys Res Commun. 2003;310(3):979–985
   PubMed Web of Science ®Google Scholar
• . Jia Z, Hallur S, Zhu H, Li Y, Misra HP. Potent upregulation of glutathione and NAD(P)H: quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: protection against neurotoxicant-elicited cytotoxicity. Neurochem Res. 2008;33(5):790–800
   PubMed Web of Science ®Google Scholar
• . Wenzel P, Hink U, Oelze M, . Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem. 2007;282(1):792–799
   PubMed Web of Science ®Google Scholar
• . He L, Liu B, Dai Z, . Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur J Pharmacol. 2012;678(1–3):32–38
   PubMed Web of Science ®Google Scholar
• . Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 2008;74(13):1526–1539
   PubMed Web of Science ®Google Scholar
• . Steinbrenner H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta. 2009;1790(11):1478–1485
   PubMed Web of Science ®Google Scholar
• . Tanguy S, Grauzam S, de LJ, Boucher F. Impact of dietary selenium intake on cardiac health: experimental approaches and human studies. Mol Nutr Food Res. 2012;56(7):1106–1121
   PubMed Web of Science ®Google Scholar
• . Robin E, Guzy RD, Loor G, . Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem. 2007;282(26):19133–19143
   PubMed Web of Science ®Google Scholar
• . Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10A):58D–68D
   PubMed Web of Science ®Google Scholar
• . Lauver DA, Lockwood SF, Lucchesi BR. Disodium disuccinate astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J Pharmacol Exp Ther. 2005;314(2):686–692
   PubMed Web of Science ®Google Scholar
• . Wolf AM, Asoh S, Hiranuma H, . Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem. 2010;21(5):381–389
   PubMed Web of Science ®Google Scholar
• . Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97(3):237–241
   PubMed Web of Science ®Google Scholar
• . Rezk BM, Haenen GR, Van der Vijgh WJ, Bast A. Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity. Identification of the antioxidant pharmacophore. FEBS Lett. 2003;555(3):601–605
   PubMed Web of Science ®Google Scholar
• . Antoniades C, Shirodaria C, Warrick N, . 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation. 2006;114(11):1193–1201
   PubMed Web of Science ®Google Scholar
• . Tawakol A, Migrino RQ, Aziz KS, . High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol. 2005;45(10):1580–1584
   PubMed Web of Science ®Google Scholar
• . Moens AL, Claeys MJ, Wuyts FL, . Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol. 2007;99(4):476–481
   PubMed Web of Science ®Google Scholar
• . McCarty MF, Barroso-Aranda J, Contreras F. High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals—clinical potential in inflammatory disorders. Med Hypotheses. 2009;73(5):824–834
   PubMed Web of Science ®Google Scholar
• . Kietadisorn R, Schmidt HH, Moens AL. Folic acid as a cardiovascular drug: dose matters. Am J Cardiol. 2010;106(11):1673–1674
   PubMed Web of Science ®Google Scholar
• . McCarty MF. Oster rediscovered—mega-dose folate for symptomatic atherosclerosis. Med Hypotheses. 2007;69(2):325–332
   PubMed Web of Science ®Google Scholar
• . Myung SK, Ju W, Cho B, . Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;346:f10
   PubMed Web of Science ®Google Scholar
• . Spiegel DM, Farmer B, Smits G, Chonchol M. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. J Ren Nutr. 2007;17(6):416–422
   PubMed Web of Science ®Google Scholar
• . De Schutter TM, Behets GJ, Geryl H, . Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int. 2013;83(6):1109–1117
   PubMed Web of Science ®Google Scholar
• . McCarty MF. A moderately low phosphate intake may provide health benefits analogous to those conferred by UV light—a further advantage of vegan diets. Med Hypotheses. 2003;61(5–6):543–560
   PubMed Web of Science ®Google Scholar
• . Ferro CJ, Chue CD, Steeds RP, Townend JN. Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart. 2009;95(21):1770–1772
   PubMed Web of Science ®Google Scholar
• . Calvo MS, Uribarri J. Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr. 2013;98(1):6–15
   PubMed Web of Science ®Google Scholar
• . Gutierrez OM. Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease. Adv Chronic Kidney Dis. 2013;20(2):150–156
   PubMed Web of Science ®Google Scholar
• . Shantouf R, Ahmadi N, Flores F, . Impact of phosphate binder type on coronary artery calcification in hemodialysis patients. Clin Nephrol. 2010;74(1):12–18
   PubMed Web of Science ®Google Scholar
• . Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009;54(4):619–637
   PubMed Web of Science ®Google Scholar
• . Jamal SA, Fitchett D, Lok CE, Mendelssohn DC, Tsuyuki RT. The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis. Nephrol Dial Transplant. 2009;24(10):3168–3174
   PubMed Web of Science ®Google Scholar
• . Rennick A, Kalakeche R, Seel L, Shepler B. Nicotinic Acid and nicotinamide: a review of their use for hyperphosphatemia in dialysis patients. Pharmacotherapy. 2013;33(6):683–690
   PubMed Web of Science ®Google Scholar
• . Maccubbin D, Tipping D, Kuznetsova O, Hanlon WA, Bostom AG. Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial. Clin J Am Soc Nephrol. 2010;5(4):582–589
   PubMed Web of Science ®Google Scholar
• . Hu S, Shearer GC, Steffes MW, Harris WS, Bostom AG. Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia. Am J Kidney Dis. 2011;57(1):181–182
   PubMed Web of Science ®Google Scholar
• . McCarty MF, DiNicolantonio JJ. Bioavailable dietary phosphate is emerging as mediator of cardiovascular disease, and may be decreased with plant-based diets, phosphate binders, niacin, and avoidance of phosphate additives. Nutrition. 2014; accepted for publication
   Google Scholar
• . Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008;100(4):593–603
   PubMed Web of Science ®Google Scholar
• . Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013;19(4):217–226
   PubMed Web of Science ®Google Scholar
• . Lerner RG, Aronow WS, Sekhri A, . Warfarin use and the risk of valvular calcification. J Thromb Haemost. 2009;7(12):2023–2027
   PubMed Web of Science ®Google Scholar
• . Bostrom K, Tsao D, Shen S, Wang Y, Demer LL. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem. 2001;276(17):14044–14052
   PubMed Web of Science ®Google Scholar
• . Wallin R, Cain D, Hutson SM, Sane DC, Loeser R. Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost. 2000;84(6):1039–1044
   PubMed Web of Science ®Google Scholar
• . Yao Y, Shahbazian A, Bostrom KI. Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. Circ Res. 2008;102(9):1065–1074
   PubMed Web of Science ®Google Scholar
• . Schurgers LJ, Barreto DV, Barreto FC, . The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010;5(4):568–575
   PubMed Web of Science ®Google Scholar
• . Dalmeijer GW, van der Schouw YT, Vermeer C, Magdeleyns EJ, Schurgers LJ, Beulens JW. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J Nutr Biochem. 2013;24(4):624–628
   PubMed Web of Science ®Google Scholar
• . Dalmeijer GW, van der Schouw YT, Magdeleyns E, Ahmed N, Vermeer C, Beulens JW. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis. 2012;225(2):397–402
   PubMed Web of Science ®Google Scholar
• . Westenfeld R, Krueger T, Schlieper G, . Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59(2):186–195
   PubMed Web of Science ®Google Scholar
• . Vermeer C. Vitamin K: the effect on health beyond coagulation—an overview. Food Nutr Res. 2012;56. doi:10.3402/fnr.v56i0.5329
   Google Scholar
• . Beulens JW, Bots ML, Atsma F, . High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203(2):489–493
   PubMed Web of Science ®Google Scholar
• . Geleijnse JM, Vermeer C, Grobbee DE, . Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100–3105
   PubMed Web of Science ®Google Scholar
• . Gast GC, de Roos NM, Sluijs I, . A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009;19(7):504–510
   PubMed Web of Science ®Google Scholar
• . Kaneki M, Hodges SJ, Hosoi T, . Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition. 2001;17(4):315–321
   PubMed Web of Science ®Google Scholar
• . Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(12):1256–1261
   PubMed Web of Science ®Google Scholar
• . Pilkey RM, Morton AR, Boffa MB, . Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis. 2007;49(3):432–439
   PubMed Web of Science ®Google Scholar
• . Cranenburg EC, Schurgers LJ, Uiterwijk HH, . Vitamin K intake and status are low in hemodialysis patients. Kidney Int. 2012;82(5):605–610
   PubMed Web of Science ®Google Scholar
• . Garcia-Canton C, Bosch E, Ramirez A, . Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011;26(7):2250–2256
   PubMed Web of Science ®Google Scholar
• . Zagura M, Serg M, Kampus P, . Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur J Vasc Endovasc Surg. 2011;42(5):689–695
   PubMed Web of Science ®Google Scholar
• . Lee SY, Kim HY, Gu SW, Kim HJ, Yang DH. 25-hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patients with chronic kidney disease. Kidney Blood Press Res. 2012;35(5):349–354
   PubMed Web of Science ®Google Scholar
• . Naves-Diaz M, Cabezas-Rodriguez I, Barrio-Vazquez S, Fernandez E, Diaz-Lopez JB, Cannata-Andia JB. Low calcidiol levels and risk of progression of aortic calcification. Osteoporos Int. 2012;23(3):1177–1182
   PubMed Web of Science ®Google Scholar
• . Schmidt N, Brandsch C, Kuhne H, Thiele A, Hirche F, Stangl GI. Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS ONE. 2012;7(4):e35316
   Web of Science ®Google Scholar
• . Zittermann A, Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol Aspects Med. 2008;29(6):423–432
   PubMed Web of Science ®Google Scholar
• . Vieth R. The mechanisms of vitamin D toxicity. Bone Miner. 1990;11(3):267–272
   PubMedGoogle Scholar
• . Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006;92(1):39–48
   PubMed Web of Science ®Google Scholar
• . Peiris AN, Youssef D, Grant WB. Secondary hyperparathyroidism: benign bystander or culpable contributor to adverse health outcomes? South Med J. 2012;105(1):36–42
   PubMed Web of Science ®Google Scholar
• . Whitfield JF. Osteogenic PTHs and vascular ossification-Is there a danger for osteoporotics? J Cell Biochem. 2005;95(3):437–444
   PubMed Web of Science ®Google Scholar
• . Cheng SL, Shao JS, Halstead LR, Distelhorst K, Sierra O, Towler DA. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res. 2010;107(2):271–282
   PubMed Web of Science ®Google Scholar
• . Graciolli FG, Neves KR, dos Reis LM, . Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. Nephrol Dial Transplant. 2009;24(5):1416–1421
   PubMed Web of Science ®Google Scholar
• . Somjen D, Weisman Y, Kohen F, . 25-hydroxyvitamin D3–1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111(13):1666–1671
   PubMed Web of Science ®Google Scholar
• . Aoshima Y, Mizobuchi M, Ogata H, . Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-alpha. Nephrol Dial Transplant. 2012;27(5):1800–1806
   PubMed Web of Science ®Google Scholar
• . Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 1998;98(13):1302–1306
   PubMed Web of Science ®Google Scholar
• . Wu-Wong JR, Noonan W, Ma J, . Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther. 2006;318(1):90–98
   PubMed Web of Science ®Google Scholar
• . Guerrero F, Montes de OA, Aguilera-Tejero E, Zafra R, Rodriguez M, Lopez I. The effect of vitamin D derivatives on vascular calcification associated with inflammation. Nephrol Dial Transplant. 2012;27(6):2206–2212
   PubMed Web of Science ®Google Scholar
• . Vieth R. Vitamin D and cancer mini-symposium: the risk of additional vitamin D. Ann Epidemiol. 2009;19(7):441–445
   PubMed Web of Science ®Google Scholar
• . Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant. 2009;24(12):3799–3805
   PubMed Web of Science ®Google Scholar
• . Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011;6(1):50–62
   PubMed Web of Science ®Google Scholar
• . Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med. 2003;349(5):446–456
   PubMed Web of Science ®Google Scholar
• . Martinez-Moreno JM, Munoz-Castaneda JR, Herencia C, . In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/beta-catenin activation. Am J Physiol Renal Physiol. 2012;303(8):F1136–F1144
   PubMed Web of Science ®Google Scholar
• . Johnson K, Polewski M, van ED, Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler Thromb Vasc Biol. 2005;25(4):686–691
   PubMed Web of Science ®Google Scholar
• . Nitta K, Akiba T, Suzuki K, . Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis. 2004;44(4):680–688
   PubMed Web of Science ®Google Scholar
• . Koshiyama H, Nakamura Y, Tanaka S, Minamikawa J. Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J Clin Endocrinol Metab. 2000;85(8):2793–2796
   PubMed Web of Science ®Google Scholar
• . Hashiba H, Aizawa S, Tamura K, Kogo H. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Ther Apher Dial. 2006;10(1):59–64
   PubMed Web of Science ®Google Scholar
• . Tamura K, Suzuki Y, Matsushita M, . Prevention of aortic calcification by etidronate in the renal failure rat model. Eur J Pharmacol. 2007;558(1–3):159–166
   PubMed Web of Science ®Google Scholar